[A lesson on the purity of pharmaceutical products derived from biotechnology: eosinophilia-myalgia syndrome].
D016603:Eosinophilia-Myalgia Syndrome / Q000503:physiopathology*; D006801:Humans; D014364:Tryptophan / Q000009:adverse effects* / Q000737:chemistry / Q000302:isolation & purification
D014364:Tryptophan